中国巨石(600176.SH):巨石埃拟投建年产12万吨玻璃纤维池窑拉丝生产线技改项目
格隆汇3月19日丨中国巨石(600176.SH)公布,公司全资子公司巨石集团有限公司之控股子公司巨石埃及拟充分利用公司现有智能制造优势和经验,对巨石埃及基地的第一条年产8万吨玻璃纤维池窑拉丝生产线进行冷修改造。技术改造完成后,该生产线产能将提升至12万吨。项目建设周期6个月,计划于2021年12月启动。项目总投资5994.30万美元,资金来源为公司自筹及银行贷款。项目建成后,预计每年可实现销售收入8878.49万美元,年平均利润总额2919.01万美元(上述数据仅为公司对项目投资收益的预计金额,不构成公司对项目投资收益的承诺)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.